Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00732342 · ClinicalTrials.gov registry record · NA
Contingency Management Treatment Duration
A NA study of Alcohol Abuse, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
- 5
- Study locations
NCT00732342 is a NA study of Alcohol Abuse that has completed, run by UConn Health. The registered enrollment target is 310 participants, below the 706-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (56% lower). The trial reports 5 study locations across 2 states.
The verdict
NCT00732342, a NA study of Alcohol Abuse, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
- 5
- Study locations
Study Summary
310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatment as usual (ST) at the clinic without contingency management (CM); (b) standard treatment with contingency management for 12 weeks with a 0.5 probability of winning prizes for each negative sample submitted; (c) standard treatment with contingency management for 24 weeks with a 0.34 probability of winning prizes for each negative sample submitted; or (d) standard treatment with contingency management for 24 weeks with a 0.5 probability of winning prizes for each negative sample submitted. We expect that contingency management will decrease alcohol use to a greater extent than non-contingency management treatment, and that availability of contingency management for 24 weeks may result in longer term benefits than 12 week exposure to contingency management. This study will be the first to evaluate the effects of probability of winning prizes on response to contingency management.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
Study Locations (5)
Connecticut
- Prospect House - Bridgeport
- Alcohol and Drug Recovery Centers, Inc. - Hartford
- The Hospital of Central Connecticut at New Britain General - New Britain
- Morris Foundation - Waterbury
Massachusetts
- Carlson Recovery Center - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2008-02 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00732342
The ClinicalTrials.gov registry entry for NCT00732342 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 706-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (56% lower). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.
NCT00732342 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00732342 about?
NCT00732342 is a clinical study titled "Contingency Management Treatment Duration". 310 alcohol abusing or dependent patients beginning intensive outpatient day treatment at community-based clinics will be randomly assigned to one of four conditions: (a) standard treatment as usual (ST) at the clinic without contingency management (CM); (b) standard treatment with contingency manag...
What is the current status of trial NCT00732342?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2008-02. Estimated completion is 2015-05.
What conditions does trial NCT00732342 study?
This clinical trial studies the following conditions: Alcohol Abuse.
What interventions are being tested in trial NCT00732342?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00732342?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00732342 being conducted?
This trial has 5 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.